--- title: "HSN Code for Other Carcino-Chemotherapeutic Drugs | HSN 30049095 GST Rate" description: "Find HSN and GST Rates for 30049095 related to Other Carcino-Chemotherapeutic Drugs with BUSY Accounting - The reliable source for HSN and GST details in India." canonical: "https://busy.in/hsn/hsn-30049095/" --- # HSN Code 30049095: Other Carcino-Chemotherapeutic Drugs - [Section 06: Guide to HSN Section 06](https://busy.in/hsn/section-06/) - [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/) - [Sub-chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/) ## GST rates | Description | CGST | SGST | IGST | CESS | | --- | --- | --- | --- | --- | | Other : Other : Carcino-chemotherapeutic drugs not elsewhere specified or included | 6% | 6% | 12% | 0% | ## Frequently asked questions ### What products are classified under HSN 30049095 ? It includes Other Carcino-Chemotherapeutic Drugs ### How should mixed supplies be billed when Other Carcino-Chemotherapeutic Drugs is sold with other items? Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Other Carcino-Chemotherapeutic Drugs; Nil for exempt items if applicable). ### Do e‑way bill and e‑invoice apply for Other Carcino-Chemotherapeutic Drugs? e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies. ### How much GST applies to Other Carcino-Chemotherapeutic Drugs? Under HSN 30049095, Other Carcino-Chemotherapeutic Drugs attracts Varies when sold in taxable form. Describe the exact form on the invoice. ### Does packaging or labelling change the GST for Other Carcino-Chemotherapeutic Drugs? For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading. ### Any common misclassification issue with Other Carcino-Chemotherapeutic Drugs? Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection. ### Can we claim ITC on inputs used to trade Other Carcino-Chemotherapeutic Drugs? If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42. ## India's trade performance: HSN Code 30049095 (FY 2024-25) Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25). - Exports: ₹98 Cr (+31.94% YoY) — 0.0027% of India's total exports - Imports: ₹74 Cr (+21.07% YoY) — 0.0012% of India's total imports - Trade balance: ₹24 Cr (Surplus); surplus rank #2704 of 12657 HSN codes - Share of Sub-Chapter 3004: 0.05% of its exports; import side 0.69% - Rank within Sub-Chapter 3004: #77 of 149 by export value; import-side #10 ### Key metrics - Export CAGR: 10.23% (FY 2018-19 to FY 2024-25, 7 fiscal years) - National export rank: #2693 of 12657 HSN codes by export value (FY 2024-25) - Peak growth year: +37.71% in FY 2020-21 - Contribution to Sub-Ch. 3004: 0.05% of its exports (FY 2024-25) ## India export-import trade statistics: HSN Code 30049095 7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB. | FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Sub-Ch. 3004 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Sub-Ch. 3004 | Trade balance | Exp rank | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | FY 2018-19 | 54.49 | 0.0024% | — | 0.06% | 1.50 | 0.0000% | — | 0.02% | +52.99 | #2734 | | FY 2019-20 | 50.36 | 0.0023% | −7.58% | 0.05% | 2.60 | 0.0001% | +73.33% | 0.03% | +47.76 | #2862 | | FY 2020-21 | 69.35 | 0.0032% | +37.71% | 0.05% | 24.89 | 0.0009% | +857.31% | 0.31% | +44.46 | #2488 | | FY 2021-22 | 49.60 | 0.0016% | −28.48% | 0.04% | 19.05 | 0.0004% | −23.46% | 0.14% | +30.55 | #3366 | | FY 2022-23 | 65.35 | 0.0018% | +31.75% | 0.05% | 42.09 | 0.0007% | +120.94% | 0.44% | +23.26 | #3118 | | FY 2023-24 | 74.08 | 0.0020% | +13.36% | 0.05% | 61.04 | 0.0011% | +45.02% | 0.63% | +13.04 | #2986 | | FY 2024-25 | 97.74 | 0.0027% | +31.94% | 0.05% | 73.90 | 0.0012% | +21.07% | 0.69% | +23.84 | #2693 | - CAGR (7-year): exports 10.23%/yr, imports 91.47%/yr (consistently Surplus) ## Key trade insights: HSN Code 30049095 export-import analysis ### Consistent export growth: 10.23% CAGR over 7 years India's exports under HSN Code 30049095 have grown at a compound annual rate of 10.23% over 7 fiscal years, rising from ₹54.49 Crore in FY 2018-19 to ₹97.74 Crore in FY 2024-25. ### HSN Code 30049095 ranked #2693 among all 12657 HSN codes by export value In FY 2024-25, HSN Code 30049095 ranks #2693 out of 12657 HSN codes by total export value. Within Sub-Chapter 3004, it ranks #77 of 149. By trade surplus, it ranks #2704 of 12657. ### FY 2020-21 was the strongest growth year for HSN Code 30049095 exports The strongest single-year export movement for HSN Code 30049095 was recorded in FY 2020-21, when exports surged by 37.71% over the prior year. ### India maintains a trade surplus of ₹23.84 Crore in HSN Code 30049095 goods In FY 2024-25, India's exports of ₹97.74 Cr exceeded imports of ₹73.90 Cr, resulting in a trade surplus of ₹23.84 Crore — ranking #2704 of 12657 by surplus magnitude. ### Import growth of 91.47% CAGR signals rising demand for Other Carcino-Chemotherapeutic Drugs India's imports under HSN Code 30049095 have grown at 91.47% CAGR, reaching ₹73.90 Crore in FY 2024-25. ### HSN Code 30049095 contributes 0.05% of Sub-Chapter 3004 exports — ranked #77 Among the 149 HSN codes under Sub-Chapter 3004, HSN Code 30049095 ranks #77 by export value — accounting for 0.05% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.69% share (rank #10). ## Related HSN Codes in Sub-Chapter 3004 Ranked by export value (FY 2024-25). | Rank | HSN Code | Exports (FY 2024-25) | | --- | --- | --- | | #1 | [HSN Code 30049099: Other therapeutic or prophylactic use products](https://busy.in/hsn/hsn-30049099/) | ₹82,761 Cr | | #2 | [HSN Code 30049049: Other \| Anticancer Drugs](https://busy.in/hsn/hsn-30049049/) | ₹19,872 Cr | | #3 | [HSN Code 30049079: Other \| Antihypertensive Drugs](https://busy.in/hsn/hsn-30049079/) | ₹9,153 Cr | | #4 | [HSN Code 30049069: Nonsteroidal Analgesics & Antipyretics: Other Medicaments](https://busy.in/hsn/hsn-30049069/) | ₹7,577 Cr | | #5 | [HSN Code 30049039: Other Antihistaminics/Antacids/Antiulcer/Antiemetics](https://busy.in/hsn/hsn-30049039/) | ₹5,465 Cr | | #6 | [HSN Code 30041090: Other Penicillins or Streptomycins](https://busy.in/hsn/hsn-30041090/) | ₹3,685 Cr | | #7 | [HSN Code 30042019: Other Cephalosporin Antibiotics](https://busy.in/hsn/hsn-30042019/) | ₹3,036 Cr | | #8 | [HSN Code 30049081: Antiepileptic & Sulfa Drugs](https://busy.in/hsn/hsn-30049081/) | ₹2,870 Cr | | #9 | [HSN Code 30049082: Other Antiepileptic Drugs](https://busy.in/hsn/hsn-30049082/) | ₹2,860 Cr | | #10 | [HSN Code 30049029: Other Anthelmintic/Antiamoebic/Antifungal Drugs](https://busy.in/hsn/hsn-30049029/) | ₹2,697 Cr | | #77 | HSN Code 30049095: Other Carcino-Chemotherapeutic Drugs (this hsn code) | ₹98 Cr |